Prognostic value of <i>KRAS</i> gene mutations in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis
The study highlights the heterogeneous prognostic impact of <i>KRAS</i> mutations in PDAC. These findings suggest that the prognostic relevance of <i>KRAS</i> mutations in PDAC may depend on clinical factors such as treatment modality and disease stage.
Authors
- Andrew Strickland
- Henry Shen (ORCID: https://orcid.org/0000-0002-2567-6002)
- B. T. O. LEE
- Saeed Aslani
- Daniel Croagh
Institutions
- The University of Melbourne (AU)
- Northern Health (AU)
- Walter and Eliza Hall Institute of Medical Research (AU)
- Peter MacCallum Cancer Centre (AU)
- Australian Regenerative Medicine Institute (AU)
- Monash Health (AU)
- Monash University (AU)
Publication Details
- Journal
- Scandinavian Journal of Gastroenterology
- Published
- 2026-01-13
- DOI
- https://doi.org/10.1080/00365521.2025.2610630
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00